{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:09:38Z","timestamp":1784563778958,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02761-9","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:02:51Z","timestamp":1701432171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure"],"prefix":"10.1007","volume":"316","author":[{"given":"Jenna","family":"Yousif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa S.","family":"Ceresnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat H.","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2761_CR1","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.18632\/aging.202472","volume":"13","author":"D Zhang","year":"2021","unstructured":"Zhang D, Wei X, Hong W, Fu L, Qian G, Xu AE (2021) A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation. Aging (Albany NY) 13:5415\u20135425","journal-title":"Aging (Albany NY)"},{"key":"2761_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0190-9622(92)70024-A","volume":"26","author":"Y Gauthier","year":"1992","unstructured":"Gauthier Y, Surleve-Bazeille JE (1992) Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol 26:191\u2013194","journal-title":"J Am Acad Dermatol"},{"key":"2761_CR3","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jisp.2017.01.001","volume":"18","author":"AF Nahhas","year":"2017","unstructured":"Nahhas AF, Mohammad TF, Hamzavi IH (2017) Vitiligo Surgery: Shuffling Melanocytes. J Investig Dermatol Symp Proc 18:S34\u2013S37","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2761_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1524-4725.1998.tb04168.x","volume":"24","author":"AM Kahn","year":"1998","unstructured":"Kahn AM, Cohen MJ (1998) Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts. Dermatol Surg 24:365\u20137","journal-title":"Dermatol Surg"},{"key":"2761_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/DSS.0000000000002382","volume":"47","author":"S Altalhab","year":"2021","unstructured":"Altalhab S, AlJasser MI (2021) Needling as a method to highlight the margins of a vitiligo patch during melanocyte-keratinocyte transplantation. Dermatol Surg 47:572","journal-title":"Dermatol Surg"},{"key":"2761_CR6","first-page":"873","volume":"27","author":"N van Geel","year":"2001","unstructured":"van Geel N, Ongenae K, De Mil M, Naeyaert JM (2001) Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study. Dermatol Surg 27:873\u2013876","journal-title":"Dermatol Surg"},{"key":"2761_CR7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/JCAS.JCAS_143_20","volume":"14","author":"SD Mutalik","year":"2021","unstructured":"Mutalik SD, Rasal YD (2021) Innovative technique for securing autologous Melanocyte-keratinocyte Cell Transplant (MKCT) suspension in stable vitiligo. J Cutan Aesthet Surg 14:132\u2013135","journal-title":"J Cutan Aesthet Surg"},{"key":"2761_CR8","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/j.jaad.2020.05.117","volume":"86","author":"B Akshi","year":"2022","unstructured":"Akshi B, Shilpa K, Harish P (2022) A novel point-of-care technique to improve graft uptake in a melanocyte-keratinocyte transplantation procedure for vitiligo of contoured areas such as the external ear. J Am Acad Dermatol 86:e191\u2013e192","journal-title":"J Am Acad Dermatol"},{"key":"2761_CR9","unstructured":"HB RH, Ashique KT (2022) Ready-to-use lip splint for post-operative dressing in blister grafting of vitiligo. Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"2761_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/DSS.0000000000001491","volume":"45","author":"S Gupta","year":"2019","unstructured":"Gupta S, Jangra R, Gupta S, Ashique K (2019) Novel technique for retention of cell suspension in melanocyte-keratinocyte transplantation procedure using glued nylon suture or mesh. Dermatol Surg 45(1):163\u2013165. https:\/\/doi.org\/10.1097\/DSS.0000000000001491","journal-title":"Dermatol Surg"},{"issue":"10","key":"2761_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/DSS.0000000000001174","volume":"43","author":"L Yao","year":"2017","unstructured":"Yao L, Liu Y, Song Y, Zhong S, Li S (2017) Successful treatment of stable vitiligo by low-density cultured autologous melanocyte transplantation combined with narrowband ultraviolet B therapy. Dermatol Surg 43(10):1281\u20131287. https:\/\/doi.org\/10.1097\/DSS.0000000000001174","journal-title":"Dermatol Surg"},{"key":"2761_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jaad.2017.01.056","volume":"77","author":"N Silpa-Archa","year":"2017","unstructured":"Silpa-Archa N, Griffith JL, Huggins RH, Henderson MD, Kerr HA, Jacobsen G et al (2017) Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas. J Am Acad Dermatol 77:318\u2013327","journal-title":"J Am Acad Dermatol"},{"key":"2761_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/DSS.0000000000003388","volume":"48","author":"S Altalhab","year":"2022","unstructured":"Altalhab S, Shalaby SS, Saadi DG, Ezzedine K, AlJasser MI (2022) Risk factors for infection after noncultured melanocyte keratinocyte transplantation for vitiligo. Dermatol Surg 48:310\u2013314","journal-title":"Dermatol Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02761-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02761-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02761-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:33:39Z","timestamp":1730741619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02761-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["2761"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02761-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"MSC is a sub-investigator for Avita Medical, Galderma Laboratories, Incyte Corporation, Clinuvel Pharmaceuticals, and The Immune Tolerance Network. IHH has served as an advisory board member for AbbVie; a consultant for Abbvie, Pfizer, Incyte, Boehringer Ingelheim, Sonoma, Union therapeutics, Novartis, Jansen, Avita Medical, Galderma Laboratories, UCB, Vimela; a principal investigator for AbbVie, Avita Medical, Bayer, Clinuvel Pharmaceuticals, Est\u00e9e Lauder, Ferndale Laboratories, Galderma Laboratories LP, Incyte Corporation, Janssen, Janssen Biotech, L\u2019oreal\/La Roche Posay, Lenicura, Pfizer, Immune Tolerance Network, and Unigen; a sub-investigator for Janssen; past-president of the Hidradenitis Suppurativa Foundation; and co-chair of the Global Vitiligo Foundation. TFM has served as an investigator for Allergan, Arcutis, Clinuvel Pharmaceuticals, Ferndale Laboratories, Incyte Corporation, Pfizer, the Immune Tolerance Network, and Unigen; a consultant for Beiersdorf; and served on an advisory board for Ferndale Laboratories.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"10"}}